Skip to main content

Advertisement

SpringerLink
Log in

Primary biliary cirrhosis: New thoughts on pathophysiology and treatment

  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

Abstract

Primary biliary cirrhosis (PBC) is an idiopathic inflammatory hepatic disorder characterized by granulomatous destruction of small bile ducts and formation of antimitochondrial antibodies. Having found that most patients with PBC have antibody reactivity to retroviral proteins, we recently cloned a retroviral sequence directly from biliary epithelium extracted from PBC livers. Further evidence for an infectious etiology of PBC has been derived from an in vitro model using normal biliary epithelial cells in culture with lymph node extracts from patients with chronic liver disease. In this model, biliary epithelial cells cocultivated with PBC lymph nodes developed a specific phenotype of PBC with immunohistochemical evidence of antimitochondrial antibody reactivity. This model has been used to show that patients with PBC harbor a transmissible agent that may be related to the cloned retrovirus. Pilot studies using antiretroviral treatment for patients with PBC have also supported the involvement of a retrovirus in the disease process. Because the antiretroviral therapy was tolerated without undue adverse events, a multicenter controlled trial is being established to determine whether patients with PBC derive significant benefit from this new line of investigation and management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Gershwin ME, Rowley M, Davis PA, et al.: Molecular biology of the 2-oxo-acid fehydrogenase vomplexes and anti-mitochondrial antibodies. In Progress in Liver Disease. Edited by Boyer JL and Ockner RK. Philadelphia: WB Saunders; 1992:47–61.

    Google Scholar 

  2. Joplin R, Gershwin ME: Ductular expression of autoantigens in primary biliary cirrhosis. Semin Liver Dis 1997, 17:97–103.

    Article  PubMed  CAS  Google Scholar 

  3. Joplin RE, Wallace LL, Lindsay JG, et al.: The human biliary epithelial cell plasma membrane antigen in primary biliary cirrhosis: pyruvate dehydrogenase X? Gastroenterology 1997, 113:1727–1733.

    Article  PubMed  CAS  Google Scholar 

  4. Lazaridis KN, Lindor KD: Management of primary biliary cirrhosis: from diagnosis to end-stage disease. Curr Gastroenterol Rep 2000, 2:94–98. A recent update detailing standard therapy and management for patients with PBC.

    PubMed  CAS  Google Scholar 

  5. Liermann-Garcia RF, Evangelista-Garcia C, McMaster P, Neuberger J: Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center. Hepatology 2001, 33:22–27.

    Article  PubMed  CAS  Google Scholar 

  6. Poupon RE, Balkau B, Eschwége E, Poupon R: A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. N Engl J Med 1991, 324:1548–1554.

    Article  PubMed  CAS  Google Scholar 

  7. Neuberger J, Thompson R: PBC and AMA: what is the connection? Hepatology 1999, 29:271–277.

    Article  PubMed  CAS  Google Scholar 

  8. Haydon G, Neuberger J: PBC: an infectious disease? Gut 2000, 47:586–588.

    Article  PubMed  CAS  Google Scholar 

  9. Metcalf J, Howel D, James O: Primary biliary cirrhosis: epidemiology helping the clinician. BMJ 1996, 312:1181–1182.

    PubMed  CAS  Google Scholar 

  10. Neuberger J: Primary biliary cirrhosis. Lancet 1997, 350:875–879.

    Article  PubMed  CAS  Google Scholar 

  11. Neuberger JM, Portmann B, MacDougall B, et al.: Recurrence of primary biliary cirrhosis after liver transplantation. N Engl J Med 1982, 306:1–4.

    Article  PubMed  CAS  Google Scholar 

  12. Van-de-Water J, Gerson LB, Ferrell LD, et al.: Immunohistochemical evidence of disease recurrence following liver transplantation for primary biliary cirrhosis. Hepatology 1996, 24:1079–1084.

    Article  PubMed  CAS  Google Scholar 

  13. Sadamoto T, Joplin R, Keogh A, et al.: Expression of pyruvate dehydrogenase complex PDC-E2 on biliary epithelial cells induced by lymph nodes from primary biliary cirrhosis. Lancet 1998, 352:1595–1596. This was the first study to demonstrate the presence of a transmissible agent in periportal lymph nodes derived from patients with PBC capable of inducing the phenotypic manifestation of disease in normal biliary epithelial cells.

    Article  PubMed  CAS  Google Scholar 

  14. Keogh A, Sadamoto T, Joplin R, et al.: Expression of pyruvate dehydrogenase complex PDC-E2 on biliary epithelial cells induced by incubation with lymph nodes from primary biliary cirrhosis [abstract]. Hepatology 1999, 30:469A.

    Article  Google Scholar 

  15. Tanaka A, Prindiville TP, Gish R, et al.: Are infectious agents involved in primary biliary cirrhosis? A PCR approach. J Hepatol 1999, 31:664–671.

    Article  PubMed  CAS  Google Scholar 

  16. Lisitsyn N, Lisitsyn N, Wigler M: Cloning the difference between two complex genomes. Science 1993, 259:946–951.

    Article  PubMed  CAS  Google Scholar 

  17. Xu L, Guo L, Joplin R, et al.: Viral induction of primary biliary cirrhosis [abstract]. J Hepatol 1997, 26:61.

    Google Scholar 

  18. Conrad B, Weissmahr RN, Boni J, et al.: A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell 1997, 90:303–313.

    Article  PubMed  CAS  Google Scholar 

  19. Lan MS, Mason A, Chen QY, et al.: HERV-K10s and immunemediated (type1) diabetes. Cell 1998, 95:14–16.

    Article  PubMed  CAS  Google Scholar 

  20. Mason AL, Xu L, Guo L, Garry RF: Retroviruses in autoimmune liver disease: genetic or environment agents? Arch Immuno ther Exp 1999, 47:289–297.

    CAS  Google Scholar 

  21. Garry RF, Fermin CD, Hart DJ, et al.: Detection of a human intracisternal A-type retroviral particle antigenically related to HIV. Science 1990, 250:1127–1129. A landmark coculture experiment documenting the isolation of a novel human retrovirus, the human intracisternal A-type particle, from salivary glands of patients with Sjögren’s syndrome.

    Article  PubMed  CAS  Google Scholar 

  22. Garry RF, Krieg AM, Cheevers WP, et al.: Retroviruses and their role in chronic inflammatory diseases and autoimmunity. In The Retroviridae. Edited by Levy JA. New York: Plenum Press; 1995:491–602. This book chapter presents a thorough discussion of animal models, human disorders, retroviral infections and immunologic mechanisms that link retroviruses with autoimmune disease.

    Google Scholar 

  23. Talal N, Dauphinee M, Dang H, et al.: Detection of serum antibodies to retroviral proteins in patients with Sjögrens syndrome. Arthritis Rheum 1990, 33:741–781.

    Article  Google Scholar 

  24. Talal N, Garry R, Alexander S, et al.: A conserved idiotype and antibodies to retroviral proteins in systemic lupus erythematosus. J Clin Invest 1990, 85:1866–1871.

    Article  PubMed  CAS  Google Scholar 

  25. Mason A, Xu L, Guo L, et al.: Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet 1998, 351:1620–1624. This Western blot study shows that the majority of patients with PBC have antibody reactivity with the human intracisternal A-type particle, a retrovirus isolated from patients with Sjögren’s syndrome.

    Article  PubMed  CAS  Google Scholar 

  26. Xu L, Guo L, Keogh A, et al.: Isolation and characterization of a novel virus associated with primary biliary cirrhosis [abstract]. Hepatology 2000, 32:297A. A preliminary abstract reporting the cloning of a novel exogenous β-retrovirus from a PBC cDNA library and the detection of viral sequences in the in vitro coculture model for PBC.

    Article  Google Scholar 

  27. Lee Y, Kaplan M: Treatment of primary biliary cirrhosis and primary sclerosing cholangitis: use of ursodeoxycholic acid. Curr Gastrenterol Rep 1999, 1:38–41. A recent update discussing the use of UDCA in patients with PBC.

    CAS  Google Scholar 

  28. Goulis J, Leandro G, Burroughs A: Randomised controlled trials of ursodeoxycholic acid therapy for primary biliary cirrhosis: a meta analysis. Lancet 1999, 354:1053–1060.

    Article  PubMed  CAS  Google Scholar 

  29. Mason A, Farr G, Xu L, et al.: Pilot study of lamivudine for patients with primary biliary cirrhosis [abstract]. J Hepatol 2001, 34:205.

    Google Scholar 

  30. Mason A, Neuberger J: Pilot study of anti-retroviral therapy for patients with primary biliary cirrhosis [abstract]. Hepatology 2001, 34:527A. A preliminary abstract reporting significant improvements in hepatic biochemistry in patients with PBC receiving combination antiretroviral treatment with Combivir.

    Google Scholar 

  31. Degott C, Zafrani ES, Callard P, et al.: Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression. Hepatology 1999, 29:1007–1012.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Gastroenterology and Hepatology, Ochsner Clinic Foundation, Richard Freeman Research Institute, 1520 Jefferson Highway, 70121, New Orleans, LA, USA

    Andrew Mason MBBS, MRCP & Sateesh Nair MD

Authors
  1. Andrew Mason MBBS, MRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sateesh Nair MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mason, A., Nair, S. Primary biliary cirrhosis: New thoughts on pathophysiology and treatment. Curr Gastroenterol Rep 4, 45–51 (2002). https://doi.org/10.1007/s11894-002-0037-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11894-002-0037-8

Keywords

Search

Navigation